Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Cerium oxide nanoparticles have widespread use in the materials industry, and have recently come into consideration for biomedical use due to their potent regenerative antioxidant properties. Given that the brain is one of the most highly oxidative organs in the body, it is subject to some of the greatest levels of oxidative stress, particularly in neurodegenerative disease. Therefore, cerium oxide nanoparticles are currently being investigated for efficacy in several neurodegenerative disorders and have shown promising levels of neuroprotection. This review discusses the basis for cerium oxide nanoparticle use in neurodegenerative disease and its hypothesized mechanism of action. The review focuses on an up‐to‐date summary of in vivo work with cerium oxide nanoparticles in animal models of neurodegenerative disease. Additionally, we examine the current state of information regarding biodistribution, toxicity, and safety for cerium oxide nanoparticles at the in vivo level. Finally, we discuss future directions that are necessary if this nanopharmaceutical is to move up from the bench to the bedside.WIREs Nanomed Nanobiotechnol 2017, 9:e1444. doi: 10.1002/wnan.1444 This article is categorized under:Therapeutic Approaches and Drug Discovery > Nanomedicine for Neurological Disease Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Redox Redux: Revisiting PTPs and the Control of Cell Signaling
Tonks, N. K. (2005) · Cell · doi:10.1016/j.cell.2005.05.016 · Cited by 702
Geraets, L., Oomen, A. G., Schroeter, J. D., Coleman, V. A., & Cassee, F. R. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs113 · Cited by 176
Induction of pulmonary fibrosis by cerium oxide nanoparticles
Ma, J. Y., Mercer, R. R., Barger, M., Schwegler-Berry, D., Scabilloni, J., Ma, J. K., & Castranova, V. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.05.005 · Cited by 142
Toxicity and bio-accumulation of inhaled cerium oxide nanoparticles in CD1 mice
Aalapati, S., Ganapathy, S., Manapuram, S., Anumolu, G., & Prakya, B. M. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.829877 · Cited by 141
Yokel, R. A., Hussain, S., Garantziotis, S., Demokritou, P., Castranova, V., & Cassee, F. R. (2014) · Environ. Sci.: Nano · doi:10.1039/c4en00039k · Cited by 136
Kumari, M., Kumari, S. I., & Grover, P. (2014) · Mutagenesis · doi:10.1093/mutage/geu038 · Cited by 78
Cited by
Bao, Q., Hu, P., Xu, Y., Cheng, T., Wei, C., Pan, L., & Shi, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b01994 · Cited by 392
Zhu, M., Zhao, C., Liu, X., Wang, X., Zhou, F., Wang, J., Hu, Y., Zhao, Y., Yao, T., Yang, L.-M., et al. (2021) · ACS Catalysis · doi:10.1021/acscatal.0c05503 · Cited by 283
Metadata
- Authors
- Rzigalinski, B. A., Carfagna, C. S., & Ehrich, M.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2016-11-08
- Volume
- 9
- Issue
- 4
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W2557511039
- Cited by
- 168
- References
- 8
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety. https://app.cochat.ai/papers/10.1002/wnan.1444
- The paper
- Rzigalinski, B. A., Carfagna, C. S., & Ehrich, M. (2017). Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1444
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.